Cas:2633-06-9 3-styryl-pyridine manufacturer & supplier

We serve Chemical Name:3-styryl-pyridine CAS:2633-06-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-styryl-pyridine

Chemical Name:3-styryl-pyridine
CAS.NO:2633-06-9
Synonyms:(E)-3-styrylpyridine;3-stilbazole;(E)-3-(2-phenylethenyl)pyridine;3-[(E)-2-phenylethenyl]pyridine;(E)-1-phenyl-2-(3-pyridyl)ethylene
Molecular Formula:C13H11N
Molecular Weight:181.23300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:302.7ºC at 760 mmHg
Density:1.092g/cm3
Index of Refraction:1.666
PSA:12.89000
Exact Mass:181.08900
LogP:3.25200

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (E)-3-styrylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(E)-1-phenyl-2-(3-pyridyl)ethylene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(E)-3-(2-phenylethenyl)pyridine Use and application,3-[(E)-2-phenylethenyl]pyridine technical grade,usp/ep/jp grade.


Related News: developing a New Deal for post-graduate research students, starting later this year with a cross-sectoral consultation led by UKRI trimethyl benzene-1,3,5-tricarboxylate manufacturers “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. 3-Chloromethyl-benzotrifluoride suppliers Grégoire brings more than 20 years of technological innovation, strategy and digital entrepreneurship experience to the team. He started his career as the founder and CEO of Andrexen, an innovative Unified Communication Cloud Platform. 1-(bromomethyl)-2-(trifluoromethoxy)benzene vendor & factory Natural Biogenex, a 100 per cent subsidiary of Natural Capsules, is speeding up its efforts to manufacture active pharmaceutical ingredients (APIs) following the recent grant from Union government’s production linked incentive (PLI) scheme to offset the import dependence. ,developing a New Deal for post-graduate research students, starting later this year with a cross-sectoral consultation led by UKRI